Directorate General Armed Forces Medical Services Tender

Work Description - NA

The Department of Defence, under the Ministry of Defence, invites bids for the procurement of medicines, specifically outlined in BOQ Title "PROCUREMENT OF MEDICINES." This tender, reference number GEM/2025/B/6147134, seeks to acquire various types of insulin including Human Insulin Analogue Glargine (Recombinant DNA origin) 450 IU/1.5 ml PFS disposable pens with needles, Insulin Glulisine Injection Cartridges (100 IU/ml of 0.3 ml), Insulin Aspart Pens (100 U/ml of 3 ml), Insulin Aspart 50% plus Protamine Crystallised Aspart 50% Pens (100 IU/ml of 3ml), Insulin Humalog Lispro Injection (Recombinant DNA origin) Cartridges (100 IU/ml of 3 ml), and Soluble Insulin Injection (40 IU/ml Human Actrapid Vial of 10 ml). The total required quantity is 4330 units. The bid process commences on May 23, 2025, at 1:00 PM and concludes on May 24, 2025, at 1:16 PM. Bids must remain valid for 180 days from the bid end date. The procuring organization is Dg Armed Forces Medical Service, located in ***********KANNUR. This tender was dated April 24, 2025.